Preprocedural TIMI flow and mortality in patients with acute myocardial infarction treated by primary angioplasty

Journal of the American College of Cardiology

Volumn 43, Issue 8, 2004, Pages 1363-1367

  De Luca, Giuseppe ^a   Ernst, Nicolette ^a   Zijlstra, Felix ^a   Van't Hof, Arnoud W J ^a   Hoorntje, Jan C A ^a   Dambrink, Jan Henk E ^a   Gosslink, A T Marcel ^a   De Boer, Menko Jan ^a   Suryapranata, Harry ^a  

^a HOSPITAL DE WEEZENLANDEN   (Netherlands)

Author keywords

CI; Confidence interval; EF; Ejection fraction; MBG; Myocardial blush grade; Odds ratio; OR; ST segment elevation myocardial infarction; STEMI; Thrombolysis In Myocardial Infarction; TIMI

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; PERTECHNETIC ACID TC 99M; STATIN; TICLOPIDINE; WARFARIN;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; BLOOD CLOT LYSIS; CAUSE OF DEATH; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEART EJECTION FRACTION; HEART INFARCTION SIZE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RADIOISOTOPE VENTRICULOGRAPHY; RECANALIZATION; ST SEGMENT ELEVATION; SURVIVAL TIME;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PREOPERATIVE CARE; RISK FACTORS; SEVERITY OF ILLNESS INDEX; STENTS; SURVIVAL RATE; THROMBOLYTIC THERAPY; TREATMENT OUTCOME;

EID: 1942516993     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2003.11.042     Document Type: Article

References (26)

1. Zijlstra F., de Boer M.J., Hoorntje J.C., et al. A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction. N Engl J Med. 328:1993;680-684.
2. the Primary Angioplasty in Myocardial Infarction Study Group, Grines C.L., Browne K.F., Marco J., et al. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. N Engl J Med. 328:1993;673-679.
3. de Boer M.J., Suryapranata H., Hoorntje J.C., et al. Limitation of infarct size and preservation of left ventricular function after primary coronary angioplasty compared with intravenous streptokinase in acute myocardial infarction. Circulation. 90:1994;753-761.
4. Zijlstra F., Beukema W.P., van't Hof A., et al. Randomized comparison of primary coronary angioplasty with thrombolytic therapy in low-risk patients with acute myocardial infarction. J Am Coll Cardiol. 29:1997;908-912.
5. Zijlstra F., Hoorntje J.C.A., de Boer M.J., et al. Long-term benefit of primary angioplasty as compared with thrombolytic therapy for acute myocardial infarction. N Engl J Med. 341:1999;1413-1419.
6. the Zwolle Myocardial Infarction Study Group, de Boer M.J., Ottervanger J.P., van't Hof A.W., et al. Reperfusion therapy in elderly patients with acute myocardial infarction A randomized comparison of primary angioplasty and thrombolytic therapy. J Am Coll Cardiol. 39:2002;1723-1728.
7. Antoniucci D., Valenti R., Migliorini A., et al. Relation of time to treatment and mortality in patients with acute myocardial infarction undergoing primary coronary angioplasty. Am J Cardiol. 89:2002;1248-1252.
8. Suryapranata H., van't Hof A., Hoorntje J.C.A., et al. Randomized comparison of coronary stenting with balloon angioplasty in selected patients with acute myocardial infarction. Circulation. 97:1998;2502-2505.
9. the Abciximab before Direct angioplasty and stenting in Myocardial Infarction Regarding Acute and Long-term follow-up (ADMIRAL) Investigators, Montalescot G., Barragan P., Wittenberg O., et al. Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction. N Engl J Med. 344:2001;1895-1903.
10. Morrow D.A., Antman E.M., Charlesworth A., et al. TIMI risk score for ST-elevation myocardial infarction A convenient, bedside, clinical score for risk assessment at presentation - an intravenous NPA for treatment of infarcting myocardium early II trial substudy. Circulation. 102:2000;2031-2037.
11. On the behalf of the Zwolle Myocardial Infarction Study Group, van't Hof A., Liem A., Suryapranata H., et al. Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction Myocardial blush grade. Circulation. 97:1998;2302-2306.
12. Zijlstra F., Ernst N., de Boer M.J., et al. Influence of prehospital administration of aspirin and heparin on initial patency of the infarct-related artery in patients with acute ST elevation myocardial infarction. J Am Coll Cardiol. 39:2002;1733-1737.
13. Flameng W., Lesaffre E., Vanhaecke J. Determinants of infarct size in non-human primates. Bas Res Cardiol. 85:1990;392-403.
14. Henriques J.P., Zijlstra F., Ottervanger J.P., et al. Incidence and clinical significance of distal embolization during primary angioplasty for acute myocardial infarction. Eur Heart J. 23:2002;1112-1117.
15. Stone G.W., Cox D., Garcia E., et al. Normal flow (TIMI-3) before mechanical reperfusion therapy is an independent determinant of survival in acute myocardial infarction Analysis from the primary angioplasty in myocardial infarction trials. Circulation. 104:2001;624-626.
16. Brodie B.R., Stuckey T.D., Hansen C., et al. Benefit of coronary reperfusion before intervention on outcomes after primary angioplasty for acute myocardial infarction. Am J Cardiol. 85:2000;13-18.
17. Zijlstra F., Patel A., Jones M., et al. Clinical characteristics and outcome of patients with early (<2 h), intermediate (2-4 h) and late (>4 h) presentation treated by primary coronary angioplasty or thrombolytic therapy for acute myocardial infarction. Eur Heart J. 23:2002;550-557.
18. Brodie B.R., Stuckey T.D., Wall T.C., et al. Importance of time to reperfusion for 30-day and late survival and recovery of left ventricular function after primary angioplasty for acute myocardial infarction. J Am Coll Cardiol. 32:1998;1312-1319.
19. Antoniucci D., Valenti R., Moschi G., et al. Relation between preintervention angiographic evidence of coronary collateral circulation and clinical and angiographic outcomes after primary angioplasty or stenting for acute myocardial infarction. Am J Cardiol. 89:2002;121-125.
20. Brodie B.R., Stuckey T.D., Hansen C.J., et al. Effect of treatment delay on outcomes in patients with acute myocardial infarction transferred from community hospitals for primary percutaneous coronary intervention. Am J Cardiol. 89:2002;1243-1247.
21. Moon J.C., Kalra P.R., Coats A.J. DANAMI-2 Is primary angioplasty superior to thrombolysis in acute MI when the patient has to be transferred to an invasive centre? Int J Cardiol. 85:2002;199-201.
22. the Prospective Evaluation of Reperfusion Markers (PERM) Study Group, Steg P.G., Laperche T., Golmard J.L., et al. Efficacy of streptokinase, but not tissue-type plasminogen activator, in achieving 90-minute patency after thrombolysis for acute myocardial infarction decreases with time to treatment. J Am Coll Cardiol. 31:1998;776-779.
23. Lamfers E.J., Hooghoudt T.E., Uppelschoten A., Stolwijk P.W., Verheugt F.W. Effect of prehospital thrombolysis on aborting acute myocardial infarction. Am J Cardiol. 84:1999;928-930.
24. Li R.H., Herrmann H.C. Facilitated percutaneous coronary intervention A novel concept in expediting and improving acute myocardial infarction care. Am Heart J. 140:(Suppl):2000;S125-S135.
25. for the PACT Investigators, Ross A.M., Coyne C.S., Reiner J.S., et al. A randomized trial comparing primary angioplasty with a strategy of short-acting thrombolysis and immediate planned rescue angioplasty in acute myocardial infarction The PACT trial. J Am Coll Cardiol. 33:1999;1528-1533.
26. the TIMI 14 Investigators, Antman E.M., Giugliano R.P., Gibson C.M., et al. Abciximab facilitates the rate and extent of thrombolysis Results of the Thrombolysis In Myocardial Infarction (TIMI) 14 trial. Circulation. 99:1999;2720-2732.